Notably, our study demonstrates that adrb1-/- zebrafish are significantly protected against the formation of CCMs, suggesting that propranolol’s therapeutic effect on CCM is through β1AR antagonism. The gene discussed is ADRB1; the disease is cerebrocostomandibular syndrome.